PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Experimental Medicine, University of Tor Vergata, Via Montpellier 1, 00133 Rome, Italy; Department of Laboratory Medicine, Tor Vergata University Hospital, Viale Oxford 81, 00133 Rome, Italy.\', \'Department of Experimental Medicine, University of Tor Vergata, Via Montpellier 1, 00133 Rome, Italy. Electronic address: nicolai@med.uniroma2.it.\', \'Virology Unit, Laboratory of Clinical Microbiology and Virology, Tor Vergata University Hospital, Viale Oxford 81, 00133 Rome, Italy.\', \'Department of Laboratory Medicine, Tor Vergata University Hospital, Viale Oxford 81, 00133 Rome, Italy.\', \'Department of Experimental Medicine, University of Tor Vergata, Via Montpellier 1, 00133 Rome, Italy; Department of Laboratory Medicine, Tor Vergata University Hospital, Viale Oxford 81, 00133 Rome, Italy; IFCC Emerging Technologies Division, Via Carlo Farini 81, 20159 Milan, Italy.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S1567-5769(21)01042-010.1016/j.intimp.2021.108406
?:hasPublicationType
?:journal
  • International immunopharmacology
is ?:pmid of
?:pmid
?:pmid
  • 34862126
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.051
?:rankingScore_hIndex
  • 94
?:title
  • Antibody response to COVID-19 vaccine: A point of view that can help to optimize dose distribution.
?:type
?:year
  • 2022

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/34862126>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/34862126>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all